glp 1 receptor agonist GLP-1 agonists show promise in treating substance use disorders Discovery of GLP-1–Based Drugs for

Hwang is also keeping her eye on how any change to compounded GLP-1 drugs may affect access in the long run

Central administration of GLP-1-(736) amide inhibits food and water intake in rats

However, these medications also face several challenges, including low stability in the body, short half-lives, poor membrane permeability, complex manufacturing processes, and high costs

Key Challenges Clinicians Should Prepare For Although more affordable GLP-1 therapies could improve access, several concerns remain

Physicians must conduct thorough screenings that account for contraindications including a history of pancreatitis, thyroid cancer, and eating disorders